• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percent of CDRH intra- and inter-Office eConsults completed on time during the month

Dictionary: CDRH uses the internal expert consultation process to acquire information and analysis on issues related to medical devices. Intra- and inter-office consultations are completed for a variety of work products requiring expertise within and across CDRH offices, including premarket device submissions, post-approval studies, and compliance and enforcement actions. Inter-office eConsults are used to facilitate the exchange of scientific information and staff expertise across CDRH, critical to making well-supported regulatory decisions. eConsult is the system CDRH uses to manage and monitor expert consult requests.

Information is current as of September 30, 2013

Fiscal Year - 2013

Skip graphic and jump to text data

TimeTargetPercent
Oct 20128588
Nov 20128588
Dec 20128588
Jan 20138588
Feb 20138588
Mar 20138592
Apr 20138589
May 20138590
Jun 20138589
Jul 20138590
Aug 20138590
Sep 20138589

FY 2013 Overall: 89%

Number of CDRH intra- and inter-Office eConsults completed on time during the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2012N/A1,602
Nov 2012N/A1,546
Dec 2012N/A1,369
Jan 2013N/A1,584
Feb 2013N/A1,422
Mar 2013N/A1,664
Apr 2013N/A1,794
May 2013N/A1,748
Jun 2013N/A1,653
Jul 2013N/A1,820
Aug 2013N/A1,780
Sep 2013N/A1,607

FY 2013 Total: 19,589

Total number of CDRH intra- and inter-Office eConsults completed during the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeTargetNumber
Oct 2012N/A1,820
Nov 2012N/A1,752
Dec 2012N/A1,547
Jan 2013N/A1,790
Feb 2013N/A1,607
Mar 2013N/A1,807
Apr 2013N/A2,017
May 2013N/A1,936
Jun 2013N/A1,860
Jul 2013N/A2,023
Aug 2013N/A1,967
Sep 2013N/A1,804

FY 2013 Total: 21,930

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.